Can diallyl trisulfide, a dietary garlic-derived compound, activate ferroptosis to overcome therapy resistance in

Angela Lincy Prem Antony Samy1, Dhruvi Shah1, Preksha Shahagadkar1

  • 1Department of Biomedical Sciences, 14681University of Illinois College of Medicine, Rockford, IL, USA.

Abstract

Insights

Diallyl trisulfide (DATS) may overcome therapy resistance in prostate cancer (PCa) by inducing ferroptosis, a unique cell death pathway. This research explores DATS as a novel therapeutic strategy for PCa patients.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Therapy resistance significantly impacts outcomes for prostate cancer (PCa) patients.
  • Diallyl trisulfide (DATS), a garlic-derived organosulfur compound, exhibits anti-cancer properties.
  • DATS targets PCa cells through apoptosis induction, reactive oxygen species generation, ferritin degradation, and increased labile iron.

Purpose of the Study:

  • To investigate the potential of DATS in inducing ferroptosis, an iron-dependent cell death, to combat therapy resistance in PCa.
  • To test the hypothesis that DATS can overcome apoptotic resistance in PCa cells.

Main Methods:

  • In vitro studies to assess DATS effects on PCa cells.
  • In vivo studies to evaluate DATS efficacy in a relevant model.

Main Results:

  • The study hypothesizes that DATS will induce ferroptosis, thereby overcoming apoptotic resistance.
  • DATS is expected to eliminate therapy resistance by promoting ferroptosis-mediated cell death.

Conclusions:

  • DATS shows promise in targeting PCa cells by overcoming apoptosis resistance.
  • Inducing ferroptosis with DATS represents a potential strategy to treat therapy-resistant prostate cancer.